Schedule of Research and Development Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Totals | $ 589 | $ 1,174 | $ 1,071 | $ 2,254 |
| Amarex Clinical Research LLC [Member] | ||||
| Research and development expenses | 105 | 94 | 118 | 200 |
| Amarex Clinical Research LLC [Member] | Pancreatic Cancer [Member] | ||||
| Research and development expenses | 105 | 94 | 118 | 192 |
| Amarex Clinical Research LLC [Member] | Post COVID Conditions [Member] | ||||
| Research and development expenses | 8 | |||
| Sterling Pharma Solutions [Member] | ||||
| Research and development expenses | 23 | |||
| Azenova Sales International [Member] | ||||
| Research and development expenses | 2 | 2 | 15 | |
| Alcami [Member] | ||||
| Research and development expenses | 8 | 3 | 8 | 10 |
| Clinical Studies [Member] | ||||
| Totals | 476 | 734 | 661 | 1,328 |
| Manufacturing and Engineering [Member] | ||||
| Totals | (93) | 144 | (23) | 324 |
| Quality Control [Member] | ||||
| Totals | 197 | 232 | 395 | 462 |
| Regulatory [Member] | ||||
| Totals | $ 9 | $ 64 | $ 38 | $ 140 |